The state of Illinois currently has 13 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Chicago, Peoria, Springfield and Urbana.
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Recruiting
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/16/2024
Locations: Sneeze wheeze and Itch Associates LLC, Normal, Illinois
Conditions: Atopic Dermatitis